Cargando…
Correction: Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling
Autores principales: | Li, Lin, Lei, Qing-song, Zhang, Shu-Jun, Kong, Ling-na, Qin, Bo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4933365/ https://www.ncbi.nlm.nih.gov/pubmed/27379545 http://dx.doi.org/10.1371/journal.pone.0159019 |
Ejemplares similares
-
Suppression of USP18 Potentiates the Anti-HBV Activity of Interferon Alpha in HepG2.2.15 Cells via JAK/STAT Signaling
por: Li, Lin, et al.
Publicado: (2016) -
HBV Integration-mediated Cell Apoptosis in HepG2.2.15
por: Hu, Xiaoge, et al.
Publicado: (2019) -
TMEM2 inhibits hepatitis B virus infection in HepG2 and HepG2.2.15 cells by activating the JAK–STAT signaling pathway
por: Zhu, X, et al.
Publicado: (2016) -
IFN-CSP Inhibiting Hepatitis B Virus in HepG2.2.15 Cells Involves JAK-STAT Signal Pathway
por: Lu, Xuemei, et al.
Publicado: (2015) -
MicroRNA-520a suppresses HBV replication in HepG2.2.15 cells by inactivating AKT
por: Sun, Wei, et al.
Publicado: (2018)